Dr. Tina Q. Tan discusses the COVID-19 vaccine in kids 5-11 years
Contemporary Pediatrics sat down with editor-in-chief Dr. Tina Q. Tan to discuss the approval of the COVID-19 vaccine for children aged 5 to 11 years and conversations with parents.
The authorization of the Pfizer/BioNTech COVID-19 vaccine in children aged 5 to 11 years has been met with positive reactions from pediatricians and many parents. As the rollout to the age group starts, allaying safety fears and knowing who to turn to for the vaccine are key. The editor-in-chief of Contemporary Pediatrics, Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, sat down with the editorial team to answer some common questions.
Infant RSV hospitalization rates 28%, 43% lower this season vs pre-COVID seasons
May 9th 2025"These findings support Advisory Committee on Immunization Practices’ recommendations for maternal vaccination or nirsevimab to protect against severe RSV disease in infants," wrote the MMWR study investigators.
